On the heels of a successful brand
announcement, the Company was also awarded five new patents,
increasing its intellectual property portfolio to 18 total issued
patents
PLEASANTON, Calif., Jan. 17,
2023 /PRNewswire/ -- At the 2023 Consumer Electronics
Show (CES), Movano Health (Nasdaq: MOVE), a purpose-driven
healthcare solutions company at the intersection of medical and
consumer devices, announced its new wearable brand, Evie. As
the first medical grade smart ring designed for women, the product
was extremely well received and garnered 10 "Best of CES" awards
from major media publications, including USA Today, CNN, Wired, Digital Trends, Tom's
Guide and more.
These top tier publications recognized Evie as best in class in
the fitness tech, health, wearable and mobile categories in large
part due to Company's plan to pursue FDA clearance on the ring's
heart rate, SpO2 and respiration rate data. Delivering
reliable, trustworthy health data to consumers in a wearable with a
unique, comfortable and open design drove a great deal of
excitement for the planned 1H23 launch.
In order to drive its continued success, the Company has also
been prolifically filing patents and was recently issued five new
U.S. patents. The new patents protect the innovations around Movano
Health's non-invasive sensor technology, which combines Radio
Frequency and mmWave capabilities onto a single Integrated Circuit
that will be integrated into various wearable devices in the
future. With these new patents, Movano Health now has 18 issued
U.S. patents, and 43 pending U.S. and International
applications.
"We built the Evie ring to address the unique health needs of
women at every stage of their lives, and the reception to the
announcement of Evie at CES from media, investors, consumers and
partners alike was outstanding," said John
Mastrototaro, CEO of Movano Health. "We're raising the bar
for women and wearables, and our resolve to be the only wearable
that is also a medical device and our timely focus on designing a
device for the unique needs of women clearly struck a chord. With
newly issued and pending patents related to our ring and future
wearable devices, we're further strengthening our solution and
building the momentum we need for our upcoming product launch."
About Movano Health
Founded in 2018, Movano Inc. (NASDAQ:MOVE) dba Movano Health is
developing a suite of purpose-driven healthcare solutions to bring
medical-grade, high-quality data to the forefront of consumer
health devices. Featuring modern form factors, Movano Health's
devices capture a comprehensive picture of a person's vital health
information and uniquely translate the data into personalized and
intelligent insights that empower consumers to live healthier and
more balanced lives. Movano Health's end-to-end solutions will soon
enable consumers, caretakers, and healthcare professionals to
utilize daily medical-grade data as a tool to proactively monitor
and manage their health. For more information on Movano
Health, visit https://movanohealth.com/.
Movano Health's Evie Ring,
which is specifically designed to address women's health concerns,
will be available for purchase in mid-2023. To stay up to date
on Evie's launch, visit https://eviering.com/.
Forward Looking Statements
This press release contains
forward-looking statements concerning our expectations,
anticipations, intentions, beliefs, or strategies regarding the
future. These forward-looking statements are based on assumptions
that we have made as of the date hereof and are subject to known
and unknown risks and uncertainties that could cause actual
results, conditions, and events to differ materially from those
anticipated. Therefore, you should not place undue reliance on
forward-looking statements. Examples of forward-looking statements
include, among others, statements we make regarding expected future
operating results; product development and features, product
releases, clinical trial, and regulatory initiatives; our
strategies, positioning and expectations for future events or
performance. Important factors that could cause actual results to
differ materially from those in the forward-looking statements are
set forth in our most recent Annual Report on Form 10-K and any
subsequent Quarterly Reports on Form 10-Q, and in our other reports
filed with the Securities and Exchange Commission, including under
the caption "Risk Factors." Any forward-looking statement in
this release speaks only as of the date of this release. We
undertake no obligation to publicly update any forward-looking
statement, whether written or oral, that may be made from time to
time, whether as a result of new information, future developments
or otherwise.
![](https://mma.prnewswire.com/media/1984306/Movano_evie_Logo.jpg)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/movano-healths-evie-ring-wins-10-best-of-ces-2023-awards-301722853.html
SOURCE Movano